HIV1 (HUMAN IMMUNODEFICIENCY VIRUS TYPE 1) CORECEPTOR TROPISM (GENOTYPE) BY SANGER SEQUENCING / EDTA PLASMA

image not found

NABL Cap Accredited     
The HIV-1 Coreceptor Tropism (Genotype) test determines whether the virus uses the CCR5 or CXCR4 coreceptor to enter cells. Using Sanger sequencing, Metropolis Healthcare accurately analyses viral genetic regions to guide advanced antiretroviral therapy decisions. This test is especially important before initiating CCR5 antagonist drugs. It helps clinicians optimise treatment and improve long-term management outcomes

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,995.00

Sample Type: EDTA PLASMA

Fasting Not Required


Notes: H0312

Frequently Asked Questions (FAQ's):

What does the HIV-1 Coreceptor Tropism test detect?
It identifies whether HIV-1 uses CCR5, CXCR4, or both coreceptors to infect cells.

Why is this test important?
Tropism results help determine eligibility for CCR5 antagonist medications.

What method is used for this test?
Metropolis performs genotypic analysis using Sanger sequencing for reliable accuracy.

Who should undergo this test?
Patients being considered for CCR5-based therapies or experiencing treatment failure.

Is fasting needed before sample collection?
No, fasting is not required.

What type of sample is needed?
EDTA plasma is required for testing.

How do results help in treatment?
They guide personalised antiretroviral therapy selection based on viral tropism.

Can this test be used for routine HIV monitoring?

No, it is indicated specifically for treatment planning, not routine viral load monitoring 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab